文献速递垂体与肾上腺疾病肥胖与代谢综合征

基于高效液相色谱-质谱联用技术的成人生长激素缺乏症代谢谱分析

High-Performance Liquid Chromatography-Mass Spectrometry-based Metabolic Profiling of Adult Growth Hormone Deficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究纳入31例成人生长激素缺乏症(AGHD)患者和31例健康对照,采用非靶向超高效液相色谱-质谱联用技术分析血清代谢物,其中11例AGHD患者接受12个月重组人生长激素(rhGH)治疗并随访。AGHD患者与健康对照的代谢模式存在明显差异,rhGH治疗改变了特定甘油磷脂和脂肪酸酯类化合物水平,40种鉴定代谢物与IGF-1 SDS、体成分及糖脂代谢指标显著相关。

要点

  • AGHD患者与健康对照的血清代谢模式存在明显差异。
  • rhGH治疗升高特定甘油磷脂类化合物并降低脂肪酸酯类化合物。
  • 40种鉴定代谢物与IGF-1 SDS、体成分及糖脂代谢指标显著相关。

核心结论

  • AGHD患者具有独特的代谢组学特征,rhGH治疗改变多种脂肪酸化合物和氨基酸的血清水平,可能有助于改善AGHD患者的代谢状态。

研究设计与样本

  • 研究纳入31例AGHD患者和31例健康对照,对所有受试者在基线时进行非靶向超高效液相色谱-质谱联用分析,并对11例AGHD患者在12个月rhGH治疗期间进行随访检测。

主要发现

  • 代谢组学分析显示AGHD患者与健康对照之间代谢模式存在明显差异,扰动通路主要包括不饱和脂肪酸生物合成、鞘脂代谢、甘油磷脂代谢以及脂肪酸延伸、降解和生物合成。
  • rhGH治疗升高了特定甘油磷脂类化合物水平并降低了脂肪酸酯类化合物水平。
  • 40种鉴定代谢物与胰岛素样生长因子-1标准差评分(IGF-1 SDS)、体成分及糖脂代谢血浆标志物之间存在显著相关性。
  • rhGH治疗期间,脱氧胆酸甘氨酸结合物与腰臀比呈统计学显著负相关,十碳酰肉碱与血清低密度脂蛋白水平呈统计学显著正相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with adult growth hormone deficiency (AGHD) are at increased risk of metabolic syndrome. Metabolic profiles in AGHD patients have been insufficiently evaluated. OBJECTIVE: This work aims to explore serum metabolite profiles by metabolomics analysis and assess potential metabolites associated with recombinant human growth hormone (rhGH) treatment. METHODS: Thirty-one AGHD patients and 31 healthy controls were enrolled. Untargeted ultra-performance liquid chromatography-coupled mass spectroscopy was conducted in all patients and controls at baseline and during 12 months of rhGH treatment in 11 AGHD patients. Data were processed by principal component analysis, variable importance in projection scoring, orthogonal partial least squares-discriminant analysis, and MetaboAnalyst 5.0. We further explored the associations between metabolites and clinical parameters. RESULTS: Metabolomics indicated a distinct metabolic pattern between AGHD patients and healthy controls. The perturbed pathways mainly include the biosynthesis of unsaturated fatty acids, sphingolipid metabolism, glycerophospholipid metabolism, fatty acid elongation, degradation, and biosynthesis. rhGH treatment increased the levels of specific glycerophospholipids compounds and reduced fatty acid ester compounds. Significant correlations existed between the 40 identified metabolites and insulin-like growth factor-1 SD score (IGF-1 SDS), body composition, and glucose and lipid metabolism plasma markers. During rhGH treatment, there was a statistically significant negative correlation between deoxycholic acid glycine conjugate and waist-to-hip ratio, while a statistically significant positive correlation existed between decanoylcarnitine and serum low-density lipoprotein levels. CONCLUSION: AGHD patients have unique metabolomic profiles. rhGH treatment alters the serum levels of several fatty acid compounds/amino acids, which may contribute to the improvement of metabolic status in AGHD patients.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yang H, Chen M, Wang Y, et al. High-Performance Liquid Chromatography-Mass Spectrometry-based Metabolic Profiling of Adult Growth Hormone Deficiency. J Clin Endocrinol Metab. 2023. PMID: 36883594. doi:10.1210/clinem/dgad129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。